Navigation Links
Formedix Partners With OpenClinica to Deliver Automated End-to-End Clinical Trial Builds

Burlington, MA (PRWEB) October 25, 2013

Formedix, leading provider of clinical trial automation software and consultancy services is excited to announce a new partnership with OpenClinica, LLC, producers of the world’s most widely used open source electronic data capture software. The two companies are collaborating to offer an integration between Formedix Origin universal clinical trial design tools and OpenClinica’s uniquely flexible open source system for Electronic Data Capture (EDC) and Clinical Data Management.

The product, named Formedix Transform for OpenClinica, reaches the market this week and joins the company’s ever-expanding range of integrations with the leading EDC systems on the market. Transform for OpenClinica, a new integration with Formedix Universal Design Tool, Origin, merges study specification and EDC build into one process to significantly reduce OpenClinica study build times--in some cases by more than 55%. Other capabilities include study build automation and drag-and-drop reuse, enhanced by leveraging portable, vendor neutral CDISC designs.

CROs and sponsors now have even greater choice when selecting an EDC system with the introduction of Transform for OpenClinica and its diverse capabilities. There is no longer a need for training and support in multiple systems because, with Formedix, training only needs to be given for one study design tool.

Earlier this year, Mark Wheeldon, CEO of Formedix, was invited to present at OC13, the 2013 OpenClinica Global Conference, discussing the use of CDISC standards to drive efficiencies in study set-up and build with OpenClinica. He also spoke in detail about how Formedix is working with partners, such as OpenClinica, to develop cutting-edge solutions to help achieve further reductions in study build times.

Mark said, “Formedix Transform enables users to design in one environment and interface with multiple systems, broadening the scope of CROs and EDC vendors. By providing a vendor neutral solution, our customers can choose one, work with all. Transform for OpenClinica will allow us to continue our ongoing mission of delivering more choice for study build, as well as reducing the need for training in multiple systems.”

He added, “We are delighted to add to our wide portfolio of Transform tools and partner with OpenClinica, to offer even more choice to our customers. We are the only independent provider of multi-vendor solutions for clinical trial automation and we continue to build our network of technology partnerships to enhance this proposition.”

Contact Formedix for more information about the universal design and build tools, or to express an interest in partnering with the company to build an EDC integration.

About Formedix

Formedix clinical trial automation software and services enable you to remove manual, expensive, inefficient and labor intensive tasks from study set-up, EDC build, validation and submission publication processes.

In fact, across every facet of your end-to-end clinical trial, the time and cost savings they deliver speak for themselves and continue to do so time and time again.

Formedix saves 68% in set-up time and 55% in EDC build time. With 70% reuse of your content, resources are cut by 23%. It’s all in the numbers.

Your Clinical Trials Automated. Everywhere.

About OpenClinica

OpenClinica, LLC is the global leader in open source EDC | CDMS software with thousands of implementations at contract research organizations, biopharmaceutical companies, academic, and government organizations. The powerful tools and superior quality system increase the speed of data collection and ensure data integrity in clinical trials. OpenClinica supports ICH, GCP, 21 CFR Part 11, HIPAA, and other regulatory guidelines, and is designed as a standards-based, extensible, and modular platform.

For more information visit

Read the full story at

Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related biology technology :

1. Formedix CEO Invited to Speak at OpenClinica Global Conference in Boston
2. Take a Standards Health Check with Formedix at DIA 49th Annual Meeting
3. Formedix to Host Executive Breakfast prior to Bay Area CDISC Network Meeting, May 23, 2013
4. Formedix and OmniComm Partner to Offer CRO and Sponsors Multi-Vendor EDC Capabilities
5. Formedix to Host Webinar: Discover Define-XML - Practical Uses Today and a Technical Deep Dive on March 14, 2013
6. Formedix Partners with Perceptive Informatics for Forthcoming Webcast, “Four Secrets to Using CDISC Standards to Enable Clinical Trial Efficiencies”
7. "Collaborate to Innovate" with Formedix at DIA Annual Meeting 2012
8. Clinical Conductor CTMS Partners with the Greater Gift Initiative to Donate Vaccines
9. Samsung BioLogics unterzeichnet strategische Herstellungspartnerschaft mit Roche
10. Samsung BioLogics Signs a Strategic Manufacturing Partnership with Roche
11. QIAGEN Announces Partnership With Clovis Oncology to Co-develop Companion Diagnostic Targeting Drug-Resistant EGFR Mutations
Post Your Comments:
(Date:10/9/2015)... Oct. 9, 2015  Pulmatrix, Inc., (NASDAQ: PULM ) ... investor conferences. th Annual BIO Investor ... (2:00 pm EDT). --> th Annual ... am PDT (2:00 pm EDT). --> Pulmatrix ... Growth Stock Conference on Thursday, October 15, 2015 at 8:30 ...
(Date:10/9/2015)... ... October 09, 2015 , ... Leading microbial genomics startup uBiome today ... understand the relationship between weight management and the microbiome. The study uses the ResearchKit ... using an iPhone app. , The uBiome app is available as a free download ...
(Date:10/8/2015)... Fla. , Oct. 8, 2015   Intrexon ... synthetic biology, today announced the appointment of Joseph ... Environment Sector, succeeding Nir Nimrodi who continues ... Vaillancourt will direct Intrexon,s endeavors to generate sustainable, biologically ... America , where he held a variety of ...
(Date:10/8/2015)... , Oct. 8, 2015  Genetic testing for mutations ... the identification of more couples at risk of having ... presented today at the 2015 American Society of Human ... in Baltimore, Maryland . The study ... (NYSE: DGX ) are presenting at the conference ...
Breaking Biology Technology:
... (a subsidiary of Elan Corporation, plc) ( ELN) ("Elan") to acquire the analgesic therapy, PRIALT(R) (ziconotide intrathecal infusion). , ... , , ... ... ...
... ... Be Discussed and Demonstrated at Philadelphia Conference , ... Chicago, IL (PRWEB) March 11, 2010 -- ClearTrial, the ... panel discussion which includes pharmaceutical analysts from Deutsche Bank and Cowen & Company at ...
... TORONTO , March 11 /PRNewswire/ - Trillium Therapeutics ... announced that it has entered into two definitive license agreements ... Children (SickKids) in Toronto, Ontario , granting Trillium exclusive ... of hematopoietic stem cell transplantation and cancer. , ...
Cached Biology Technology:
(Date:10/7/2015)... Sweden , October 8, 2015 ... the revenues for Fingerprint Cards (FPC) during third quarter 2015 ... revenue guidance of around 860 MSEK that was communicated 20 ... Considering a further strengthened delivery capacity and a continued growing ... quarter 2015 is estimated to be higher than during the ...
(Date:10/6/2015)... LAKE CITY , Oct. 6, 2015 ... company, announced today that it has signed a contract ... monitoring services across the full range of sentences under ... Group,s President of the Americas. "This contract with the ... region of the US and advances our position as ...
(Date:10/5/2015)... ) releases the following ... NXTD ), a biometric authentication company focused on the ... ) releases the following market and company update ... authentication company focused on the growing mobile commerce market. ... ) releases the following market and company update ...
Breaking Biology News(10 mins):
... the most commonly cultivated cacao plant in the world ... this week. Researchers have utilised high quality DNA sequences to ... markers that can lead to higher yielding cocoa plants that still ... the cacao tree ( Theobroma cacao L. ...
... species, according to a new study led by Woods ... published in the journal PLOS ONE . Because ... may have far-reaching effects on the ocean environment and ... the center of the ocean ecosystemnearly all animals are ...
... insecurity increases the risk of death among injection drug ... life-prolonging antiretroviral therapy (ART), according to a new study ... the peer-reviewed science journal, PLoS One , examines ... among injection drug users. Food insecurity is defined by ...
Cached Biology News:
... Software reads and processes raw ... microarray data for analysis. ... one 2-year license for Feature ... , * one CD-ROM ...
... imported for data analysis , Automatic grid, subgrid ... template assignment , ... Extensive background and signal options to optimize, ... results , ...
... DNA Gel Stain combo offers these benefits: ... products separately Offers a ... Eliminates risks to yourself, the environment ... from 100 bp to >30 kb. UltraPure Agarose is ...
... stocks contained in standard 96-well microtiter plates. ... approximately 5,000 clones per plate. After positive ... the corresponding subplate is screened with a ... well(s). Cells from a positive well are ...
Biology Products: